Medical Weight Loss for Derry, New Hampshire Residents

Derry, New Hampshire residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Derry through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Serving Derry, New Hampshire by telehealth: your consultation, prescription, and follow-ups all happen by secure video, with compounded medication shipped to your door. Our only physical clinic is in Costa Mesa, California; everything else is virtual. Doctor review just $119 (medication separate).

Why Derry Residents Choose New Hope Weight Loss

Continuity is the quiet advantage Derry patients notice most. Because Dr. Anjmun Sharma oversees your case throughout, the person adjusting your dose in month three is the same physician who reviewed you in week one. Nothing gets lost in a handoff. That consistency, delivered by telehealth from our Costa Mesa clinic, is what turns a prescription into actual ongoing care for people all over New Hampshire.

Derry patients are cared for entirely through telehealth from our Costa Mesa, California clinic. There is no travel, your consultation with Dr. Sharma, prescription, and follow-ups all happen by secure video.

Telehealth is what lets us care for Derry, New Hampshire from a single office in Costa Mesa, so you get Dr. Sharma's full attention without rearranging your day around an appointment across town. We care for patients throughout downtown Derry and the greater Rockingham County area of southern New Hampshire. Because everything happens by telehealth, patients across downtown Derry and the greater Rockingham County area of southern New Hampshire get the same physician-led program without driving anywhere or sitting in a waiting room.

There is no separate "out of town" rate, so Derry and New Hampshire patients get the same program at the same price as everyone Dr. Sharma sees. Please note that our compounded semaglutide and tirzepatide are not FDA-approved and are not brand-identical, and results vary from person to person. New Hope Weight Loss reaches patients all across New Hampshire by secure telehealth from our Costa Mesa, California clinic, delivering physician-supervised care without any travel.

GLP-1 Weight Loss Programs Available

Begin your reset: semaglutide, from $166/mo

The 90-Day Metabolic Reset gives Derry patients a structured three-month plan with semaglutide, the active ingredient shared with Wegovy and Ozempic. Choose $166 a month or $499 for the whole 90 days. In trials of the branded drug, the average was around 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary.

Go further: tirzepatide, from $233/mo

Tirzepatide hits both GLP-1 and GIP receptors for a dual effect. Qualifying doses in branded-drug trials reached up to 22.5 percent loss, which is not what most patients should expect. It carries the same active ingredient as Mounjaro and Zepbound.

Each plan begins with a $119 physician review. Medication is billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Derry

No waiting rooms, no commute across Derry traffic. Everything happens online. You answer a focused intake quiz about your goals and medical background, Dr. Anjmun Sharma reviews it and sees you by secure video (usually within 48 hours), and if a compounded GLP-1 is appropriate she sends the prescription to a state-licensed 503(a) pharmacy. That pharmacy ships your semaglutide or tirzepatide to your Derry home in cold-pack packaging that keeps it cool the whole way. Follow-up visits are by video as well, so dose adjustments and questions are handled from wherever you are in .

Frequently Asked Questions, Derry

Does New Hope Weight Loss actually serve Derry, or only Costa Mesa?

We serve both. Our single physical location sits in Costa Mesa, California, and we extend care to Derry, New Hampshire through telehealth. Residents across neighborhoods like downtown Derry and the greater Rockingham County area of southern New Hampshire qualify the same way. Dr. Anjmun Sharma evaluates whether a compounded GLP-1 plan fits you during your initial video appointment.

Can the whole process be done remotely from Derry?

Yes, it is fully remote. There is no in-person requirement for Derry patients at any stage. You meet Dr. Sharma over video, complete intake online, and receive ongoing support by message. Approved prescriptions arrive at your door in insulated cold-pack shipping that protects the medication during delivery.

How much will a Derry patient pay?

Plan on $119 for the physician visit. Semaglutide runs from $166 monthly, with a $499 option for 90 days, and tirzepatide from $233 monthly. The medication cost is separate from the visit. HSA, FSA, Klarna, and Affirm are all welcome, and Derry residents pay no added distance fee.

What areas of Derry do you serve?

We serve patients from across Derry by telehealth, including downtown Derry and the greater Rockingham County area of southern New Hampshire.

Is my health information private as a Derry patient?

Yes. Your intake, video visits, and records are handled under HIPAA safeguards, and medication arrives in discreet packaging. Derry patients get the same confidentiality as any telehealth patient.

Derry Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Derry, New Hampshire by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.